Biotech Stock Picking - 2003 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking - 2003

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (124)	1/22/2003 8:09:43 AM
From: Arthur Radley	of 383

Several of "you" have MLNM in your portfolios....good luck with this news today and those suffering from this disease. Millennium Submits New Drug Application for VELCADE(TM) (Bortezomib) for Injection Wednesday January 22, 7:59 am ET -- Novel therapy also granted Orphan Product Designation -- CAMBRIDGE, Mass., Jan. 22 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - News) today announced that it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market VELCADE as a treatment for relapsed and refractory multiple myeloma. In June 2002, VELCADE was granted fast-track status by the FDA as having the potential to treat a serious, life- threatening condition and address an unmet medical need. The NDA was submitted under the provisions of Subpart H - Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next